{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:55:41Z","timestamp":1790178941337,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Australian Institute of Tropical Health and Medicine"},{"DOI":"10.13039\/501100000940","name":"Arthritis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10787-018-0464-2","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T05:09:42Z","timestamp":1522732182000},"page":"1219-1232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Flavonoid quercetin\u2013methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8702-0490","authenticated-orcid":false,"given":"Nagaraja","family":"Haleagrahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socorro","family":"Miranda-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama Bangra","family":"Kulur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natkunam","family":"Ketheesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"issue":"4","key":"464_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3945\/an.113.005603","volume":"5","author":"MA Alam","year":"2014","unstructured":"Alam MA, Subhan N, Rahman MM, Uddin SJ, Reza HM, Sarker SD (2014) Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr 5(4):404\u2013417","journal-title":"Adv Nutr"},{"issue":"1","key":"464_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00281-003-0127-1","volume":"25","author":"DD Brand","year":"2003","unstructured":"Brand DD, Kang AH, Rosloniec EF (2003) Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol 25(1):3\u201318","journal-title":"Springer Semin Immunopathol"},{"key":"464_CR3","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1172\/JCI36389","volume":"118","author":"FM Brennan","year":"2008","unstructured":"Brennan FM, McInnes IB (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118:3537\u20133545","journal-title":"J Clin Invest"},{"key":"464_CR4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","volume":"12","author":"PM Brown","year":"2016","unstructured":"Brown PM, Pratt AG, Isaacs JD (2016) Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. Nat Rev Rheumatol 12:731\u2013742","journal-title":"Nat Rev Rheumatol"},{"key":"464_CR5","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1021\/jf001413m","volume":"49","author":"SW Burda","year":"2001","unstructured":"Burda SW, Oleszek W (2001) Antioxidant and antiradical activities of flavonoids. J Agric Food Chem 49:2774\u20132779","journal-title":"J Agric Food Chem"},{"key":"464_CR6","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R","volume":"30","author":"IK Campbell","year":"2000","unstructured":"Campbell IK, Hamilton JA, Wicks IP (2000) Collagen-induced arthritis in C57BL\/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 30:1568\u20131575","journal-title":"Eur J Immunol"},{"issue":"8","key":"464_CR7","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00296-009-1089-y","volume":"30","author":"HM Choi","year":"2010","unstructured":"Choi HM, Oh DH, Bang JS, Yang HI, Yoo MC, Kim KS (2010) Differential effect of IL-1beta and TNF alpha on the production of IL-6, IL-8 and PGE2 in fibroblast-like synoviocytes and THP-1 macrophages. Rheumatol Int 30(8):1025\u20131033","journal-title":"Rheumatol Int"},{"issue":"12","key":"464_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1056\/NEJM200103223441207","volume":"344","author":"EH Choy","year":"2001","unstructured":"Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344(12):907\u2013916","journal-title":"N Engl J Med"},{"key":"464_CR9","first-page":"16","volume":"2","author":"IM Clark","year":"2000","unstructured":"Clark IM, Rowan AD, Cawston TE (2000) Matrix metalloproteinase inhibitors in the treatment of arthritis. Curr Opin Anti Inflamm Immunomodulat Invest Drugs 2:16\u201325","journal-title":"Curr Opin Anti Inflamm Immunomodulat Invest Drugs"},{"key":"464_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/eji.200425778","volume":"35","author":"M Comalada","year":"2005","unstructured":"Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Galvez J (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35:584\u2013592","journal-title":"Eur J Immunol"},{"key":"464_CR11","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.bcp.2006.07.016","volume":"72","author":"M Comalada","year":"2006","unstructured":"Comalada M, Ballester I, Bail\u00f3n E, Sierra S, Xaus J, G\u00e1lvez J, de Medina FS, Zarzuelo A (2006) Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure\u2013activity relationship. Biochem Pharmacol 72:1010\u20131021","journal-title":"Biochem Pharmacol"},{"issue":"5396","key":"464_CR12","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1126\/science.282.5396.2092","volume":"282","author":"C Dong","year":"1998","unstructured":"Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA (1998) Defective T cell differentiation in the absence of Jnk1. Science (New York, NY) 282(5396):2092\u20132095","journal-title":"Science (New York, NY)"},{"key":"464_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","volume":"14","author":"M Feldmann","year":"1996","unstructured":"Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397\u2013440","journal-title":"Annu Rev Immunol"},{"key":"464_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356\u2013361","journal-title":"Nature"},{"key":"464_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11926-009-0052-y","volume":"11","author":"SL Gaffen","year":"2009","unstructured":"Gaffen SL (2009) Role of IL-17 in the pathogenesis of rheumatoid arthritis. Curr Rheumatol Rep 11:365\u2013370","journal-title":"Curr Rheumatol Rep"},{"key":"464_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.abb.2015.08.008","volume":"583","author":"C Gardi","year":"2015","unstructured":"Gardi C, Bauerova K, Stringa B, Kuncirova V, Slovak L, Ponist S, Drafi F, Bezakova L, Tedesco I, Acquaviva A, Bilotto S, Russo GL (2015) Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis. Arch Biochem Biophys 583:150\u2013157","journal-title":"Arch Biochem Biophys"},{"issue":"18","key":"464_CR17","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1002\/cbic.201000487","volume":"11","author":"M Goettert","year":"2010","unstructured":"Goettert M, Schattel V, Koch P, Merfort I, Laufer S (2010) Biological evaluation and structural determinants of p38alpha mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids. ChemBioChem Eur J Chem Biol 11(18):2579\u20132588","journal-title":"ChemBioChem Eur J Chem Biol"},{"issue":"9","key":"464_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0014-827X(01)01111-9","volume":"56","author":"T Guardia","year":"2001","unstructured":"Guardia T, Rotelli AE, Juarez AO, Pelzer LE (2001) Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 56(9):683\u2013687","journal-title":"Farmaco"},{"issue":"1\u20133","key":"464_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejphar.2009.08.030","volume":"621","author":"N Haleagrahara","year":"2009","unstructured":"Haleagrahara N, Radhakrishnan A, Lee N, Kumar P (2009) Flavonoid quercetin protects against swimming stress-induced changes in oxidative biomarkers in the hypothalamus of rats. Eur J Pharmacol 621(1\u20133):46\u201352","journal-title":"Eur J Pharmacol"},{"key":"464_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.semarthrit.2010.10.004","volume":"40","author":"B Haraoui","year":"2011","unstructured":"Haraoui B, Pope J (2011) Treatment of early rheumatoid arthritis: concepts in management. Semin Arthritis Rheum 40:371\u2013388","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"464_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/ard.2005.037176","volume":"65","author":"JJ Haringman","year":"2006","unstructured":"Haringman JJ, Smeets TJ, Reinders-Blankert P, Tak PP (2006) Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis 65(3):294\u2013300","journal-title":"Ann Rheum Dis"},{"key":"464_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0047-6374(01)00371-2","volume":"1","author":"R Holmdahl","year":"2002","unstructured":"Holmdahl R, Bockermann R, Backlund J, Yamada H (2002) The molecular pathogenesis of collagen-induced arthritis in mice\u2014a model for rheumatoid arthritis. Ageing Res Rev 1:135\u2013147","journal-title":"Ageing Res Rev"},{"issue":"1","key":"464_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2133\/dmpk.DMPK-13-RV-119","volume":"29","author":"K Inoue","year":"2014","unstructured":"Inoue K, Yuasa H (2014) Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy. Drug Metab Pharmacokinet 29(1):12\u201319","journal-title":"Drug Metab Pharmacokinet"},{"key":"464_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/bs.pmbts.2017.03.002","volume":"148","author":"Y Itoh","year":"2017","unstructured":"Itoh Y (2017) Metalloproteinases in rheumatoid arthritis: potential therapeutic targets to improve current therapies. Prog Mol Biol Transl Sci 148:327\u2013338","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"18","key":"464_CR25","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1111\/j.1742-4658.2008.06580.x","volume":"275","author":"T Iwamoto","year":"2008","unstructured":"Iwamoto T, Okamoto H, Toyama Y, Momohara S (2008) Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J 275(18):4448\u20134455","journal-title":"FEBS J"},{"issue":"4","key":"464_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00011-006-0067-z","volume":"55","author":"JK Jackson","year":"2006","unstructured":"Jackson JK, Higo T, Hunter WL, Burt HM (2006) The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res 55(4):168\u2013175","journal-title":"Inflamm Res"},{"issue":"1","key":"464_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/rheumatology\/keh512","volume":"44","author":"AJ Kinder","year":"2005","unstructured":"Kinder AJ, Hassell AB, Brand J, Brownfield A, Grove M, Shadforth MF (2005) The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions. Rheumatology 44(1):61\u201366","journal-title":"Rheumatology"},{"key":"464_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1006\/clim.1998.4618","volume":"90","author":"PA Klimiuk","year":"1999","unstructured":"Klimiuk PA, Yang H, Goronzy JJ, Weyand CM (1999) Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent. Clin Immunol 90:65\u201378","journal-title":"Clin Immunol"},{"key":"464_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5604\/17322693.1135423","volume":"69","author":"A Kobyli\u0144ska","year":"2015","unstructured":"Kobyli\u0144ska A, Janas KM (2015) Health-promoting effect of quercetin in human diet. Postepy Hig Med Dosw 69:51\u201362","journal-title":"Postepy Hig Med Dosw"},{"issue":"13","key":"464_CR30","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1021\/acs.jmedchem.5b01750","volume":"59","author":"A Koeberle","year":"2016","unstructured":"Koeberle A, Laufer SA, Werz O (2016) Design and development of microsomal prostaglandin E2 synthase-1 inhibitors: challenges and future directions. J Med Chem 59(13):5970\u20135986","journal-title":"J Med Chem"},{"issue":"5","key":"464_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3109\/s10165-012-0782-y","volume":"3","author":"T Kojima","year":"2013","unstructured":"Kojima T, Yabe Y, Kaneko A, Hirano Y, Ishikawa H, Hayashi M et al (2013) Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis. Mod Rheumatol 3(5):977\u2013985","journal-title":"Mod Rheumatol"},{"issue":"1","key":"464_CR32","doi-asserted-by":"publisher","first-page":"e000287","DOI":"10.1136\/rmdopen-2016-000287","volume":"2","author":"JM Kremer","year":"2016","unstructured":"Kremer JM, Lawrence DA, Hamilton R, McInnes IB (2016) Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measures. RMD Open 2(1):e000287","journal-title":"RMD Open"},{"issue":"5","key":"464_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/1756-185X.13091","volume":"20","author":"M Lahiri","year":"2017","unstructured":"Lahiri M, Santosa A, Teoh LK, Clayton JA, Lim SY, Teng GG, Cheung PPM (2017) Use of complementary and alternative medicines is associated with delay to initiation of disease-modifying anti-rheumatic drug therapy in early inflammatory arthritis. Int J Rheum Dis 20(5):567\u2013575","journal-title":"Int J Rheum Dis"},{"key":"464_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00011-012-0459-1","volume":"61","author":"YH Lee","year":"2012","unstructured":"Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2012) The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis. Inflamm Res 61:665\u2013671","journal-title":"Inflamm Res"},{"issue":"3","key":"464_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/nu8030167","volume":"8","author":"Y Li","year":"2016","unstructured":"Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S et al (2016) Quercetin, inflammation and immunity. Nutrients 8(3):167","journal-title":"Nutrients"},{"key":"464_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2174\/1381612820666140825122247","volume":"21","author":"E Lubberts","year":"2014","unstructured":"Lubberts E (2014) Role of T lymphocytes in the development of rheumatoid arthritis. Implications for treatment. Curr Pharm Des 21:142\u2013146","journal-title":"Curr Pharm Des"},{"key":"464_CR37","doi-asserted-by":"publisher","first-page":"179284","DOI":"10.1155\/2014\/179284","volume":"2014","author":"J-D Ma","year":"2014","unstructured":"Ma J-D, Zhou J-J, Zheng D-H, Chen L-F, Mo Y-Q, Wei X, Yang L-J, Dai L (2014) Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis. Mediators Inflamm 2014:179284","journal-title":"Mediators Inflamm"},{"issue":"3","key":"464_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/NHH.0000000000000203","volume":"33","author":"DR Mager","year":"2015","unstructured":"Mager DR (2015) Methotrexate. Home Healthc Now 33(3):139\u2013141","journal-title":"Home Healthc Now"},{"key":"464_CR39","doi-asserted-by":"publisher","first-page":"e63784","DOI":"10.1371\/journal.pone.0063784","volume":"8","author":"MF Mahmoud","year":"2013","unstructured":"Mahmoud MF, EI Hassan NA, Bassossy HM, Fahmy A (2013) Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation. PLoS ONE 8:e63784","journal-title":"PLoS ONE"},{"key":"464_CR40","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.bcp.2006.08.001","volume":"72","author":"M Mamani-Matsuda","year":"2006","unstructured":"Mamani-Matsuda M, Kauss T, Al-Kharrat A, Rambert J, Fawaz F, Thiolat D, Moynet D, Coves S, Malvy D, Mossalayi MD (2006) Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochem Pharmacol 72:1304\u20131310","journal-title":"Biochem Pharmacol"},{"key":"464_CR41","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1136\/ard.2010.134684","volume":"69","author":"IB McInnes","year":"2010","unstructured":"McInnes IB, O\u2019Dell JR (2010) State-of-the-art: rheumatoid arthritis. Ann Rheum Dis 69:1898\u20131906","journal-title":"Ann Rheum Dis"},{"key":"464_CR42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429\u2013442","journal-title":"Nat Rev Immunol"},{"key":"464_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/art.1780400302","volume":"40","author":"LW Moreland","year":"1997","unstructured":"Moreland LW, Heck LW Jr, Koopman WJ (1997) Biologic agents for treating rheumatoid arthritis: concepts and progress. Arthritis Rheum 40:397\u2013409","journal-title":"Arthritis Rheum"},{"key":"464_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/art.1780390116","volume":"39","author":"D Mulherin","year":"1996","unstructured":"Mulherin D, Fitzgerald O, Bresnihan B (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39:115\u2013124","journal-title":"Arthritis Rheum"},{"key":"464_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ncprheum0047","volume":"1","author":"U Muller-Ladner","year":"2005","unstructured":"Muller-Ladner U, Pap T, Gay RE, Neidhart M, Gay S (2005) Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol 1:102\u2013110","journal-title":"Nat Clin Pract Rheumatol"},{"key":"464_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10238-009-0064-y","volume":"10","author":"F Nagatomo","year":"2010","unstructured":"Nagatomo F, Fugino NGH, Okiura T, Morimatsu F, Takeda I, Ishihara A (2010) Effects of exposure to hyperbaric oxygen on oxidative stress in rats with type II collagen-induced arthritis. Clin Exp Med 10:7\u201313","journal-title":"Clin Exp Med"},{"key":"464_CR47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/BOR.0b013e3282fb7caa","volume":"20","author":"P Nandi","year":"2008","unstructured":"Nandi P, Kingsley G, Scott D (2008) Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis. Curr Opin Rheumatol 20:251\u2013256","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"464_CR48","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.4049\/jimmunol.167.9.5381","volume":"167","author":"T Nanki","year":"2001","unstructured":"Nanki T, Nagasaka K, Hayashida K, Saita Y, Miyasaka N (2001) Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol (Baltimore, Md: 1950) 167(9):5381\u20135385","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"5","key":"464_CR49","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00003495-200565050-00006","volume":"65","author":"MT Nurmohamed","year":"2005","unstructured":"Nurmohamed MT, Dijkmans BA (2005) Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis. Drugs 65(5):661\u2013694","journal-title":"Drugs"},{"key":"464_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/art.25063","volume":"62","author":"H Okamoto","year":"2010","unstructured":"Okamoto H, Yoshio T, Kaneko H, Yamanaka H (2010) Inhibition of NF-kappa B signalling by fasudil as a potential therapeutic strategy for rheumatoid arthritis. Arthritis Rheum 62:82\u201392","journal-title":"Arthritis Rheum"},{"issue":"6","key":"464_CR51","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3945\/jn.111.157263","volume":"142","author":"SK Panchal","year":"2012","unstructured":"Panchal SK, Poudyal H, Brown L (2012) Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. J Nutr 142(6):1026\u20131032","journal-title":"J Nutr"},{"key":"464_CR52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00005-007-0032-8","volume":"55","author":"A Paradowska","year":"2007","unstructured":"Paradowska A, Ma\u015bli\u0144iski W, Grzybowska-Kowalczyk A, \u0141acki J (2007) The function of interleukin 17 in the pathogenesis of rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) 55:329\u2013334","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"6","key":"464_CR53","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.mam.2010.09.002","volume":"31","author":"F Perez-Vizcaino","year":"2010","unstructured":"Perez-Vizcaino F, Duarte J (2010) Flavonols and cardiovascular disease. Mol Aspects Med 31(6):478\u2013494","journal-title":"Mol Aspects Med"},{"issue":"1","key":"464_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2249.2004.02499.x","volume":"137","author":"I Rioja","year":"2004","unstructured":"Rioja I, Bush KA, Buckton JB, Dickson MC, Life PF (2004) Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin Exp Immunol 137(1):65\u201373","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"464_CR55","first-page":"439","volume":"27","author":"DM Roeleveld","year":"2013","unstructured":"Roeleveld DM, van Nieuwenhuijze AE, van den Berg WB, Koenders MI (2013) The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders. BioDrugs Clin Immunother Biopharm Gene Ther 27(5):439\u2013452","journal-title":"BioDrugs Clin Immunother Biopharm Gene Ther"},{"key":"464_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.nutr.22.111401.144957","volume":"22","author":"JA Ross","year":"2002","unstructured":"Ross JA, Kasum CM (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22:19\u201334","journal-title":"Annu Rev Nutr"},{"key":"464_CR57","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1043-6618(03)00225-1","volume":"48","author":"AE Rotelli","year":"2003","unstructured":"Rotelli AE, Guardia T, Juarez AO, de la Rocha NE, Pelzer LE (2003) Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res 48:601\u2013606","journal-title":"Pharmacol Res"},{"key":"464_CR58","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P et al (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74:480\u2013489","journal-title":"Ann Rheum Dis"},{"issue":"1\u20133","key":"464_CR59","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejphar.2010.07.001","volume":"644","author":"AC Saragusti","year":"2010","unstructured":"Saragusti AC, Ortega MG, Cabrera JL, Estrin DA, Marti MA, Chiabrando GA (2010) Inhibitory effect of quercetin on matrix metalloproteinase 9 activity molecular mechanism and structure-activity relationship of the flavonoid-enzyme interaction. Eur J Pharmacol 644(1\u20133):138\u2013145","journal-title":"Eur J Pharmacol"},{"key":"464_CR60","first-page":"1680","volume":"24","author":"M Sato","year":"1997","unstructured":"Sato M, Miyazaki T, Kambe F, Maeda K, Seo H (1997) Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 24:1680\u20131684","journal-title":"J Rheumatol"},{"key":"464_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2110","volume":"9","author":"G Schett","year":"2007","unstructured":"Schett G (2007) Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Res Ther 9:1\u20136","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"464_CR62","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1136\/ard.2007.074278","volume":"67","author":"G Schett","year":"2008","unstructured":"Schett G, Zwerina J, Firestein G (2008) The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis. Ann Rheum Dis 67(7):909\u2013916","journal-title":"Ann Rheum Dis"},{"key":"464_CR63","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TWJ (2010) Rheumatoid arthritis. Lancet 376:1094\u20131108","journal-title":"Lancet"},{"issue":"22","key":"464_CR64","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/archinte.166.22.2490","volume":"166","author":"NA Shadick","year":"2006","unstructured":"Shadick NA, Cook NR, Karlson EW, Ridker PM, Maher NE, Manson JE, Buring JE, Lee IM (2006) C-reactive protein in the prediction of rheumatoid arthritis in women. Arch Intern Med 166(22):2490\u20132494","journal-title":"Arch Intern Med"},{"issue":"2","key":"464_CR65","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00005-011-0116-3","volume":"59","author":"S Shiozawa","year":"2011","unstructured":"Shiozawa S, Tsumiyama K, Yoshida K, Hashiramoto A (2011) Pathogenesis of joint destruction in rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) 59(2):89\u201395","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"3","key":"464_CR66","first-page":"220","volume":"69","author":"I Simsek","year":"2011","unstructured":"Simsek I (2011) TNF inhibitors for rheumatoid arthritis\u2014a year in review. Bull NYU Hosp Jt Dis 69(3):220\u2013224","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"6","key":"464_CR67","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1586\/17512433.2015.1077698","volume":"8","author":"S Subesinghe","year":"2015","unstructured":"Subesinghe S, Scott IC (2015) Key findings from studies of methotrexate tapering and withdrawal in rheumatoid arthritis. Expert Rev Clin Pharmacol 8(6):751\u2013760","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"464_CR68","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.intimp.2013.11.014","volume":"18","author":"Y Sun","year":"2014","unstructured":"Sun Y, Yao Y, Ding CZ (2014) A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines. Int Immunopharmacol 18(1):135\u2013141","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"464_CR69","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s10753-012-9473-2","volume":"35","author":"MS Sung","year":"2012","unstructured":"Sung MS, Lee EG, Jeon HS, Chae HJ, Park SJ, Lee YC et al (2012) Quercetin inhibits IL-1beta-induced proliferation and production of MMPs, COX-2, and PGE2 by rheumatoid synovial fibroblast. Inflammation 35(4):1585\u20131594","journal-title":"Inflammation"},{"key":"464_CR70","doi-asserted-by":"publisher","first-page":"230805","DOI":"10.1155\/2013\/230805","volume":"2013","author":"SA Syggelos","year":"2013","unstructured":"Syggelos SA, Aletras AJ, Smirlaki I, Skandalis SS (2013) Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis: focus on matrix metalloproteinases, their endogenous tissue inhibitors, and the proteasome. Biomed Res Int 2013:230805","journal-title":"Biomed Res Int"},{"key":"464_CR71","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1172\/JCI115480","volume":"88","author":"EN Unemori","year":"1991","unstructured":"Unemori EN, Hibbs MS, Amento EP (1991) Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 88:1656\u20131662","journal-title":"J Clin Invest"},{"issue":"3","key":"464_CR72","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/BOR.0b013e3282fa13db","volume":"20","author":"SM van der Kooij","year":"2008","unstructured":"van der Kooij SM, Allaart CF, Dijkmans BA, Breedveld FC (2008) Innovative treatment strategies for patients with rheumatoid arthritis. Curr Opin Rheumatol 20(3):287\u2013294","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"464_CR73","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00281-017-0633-1","volume":"39","author":"DJ Veale","year":"2017","unstructured":"Veale DJ, Orr C, Fearon U (2017) Cellular and molecular perspectives in rheumatoid arthritis. Semin Immunopathol 39(4):343\u2013354","journal-title":"Semin Immunopathol"},{"key":"464_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-016-0236-6","author":"X Wang","year":"2016","unstructured":"Wang X, Yan X, Wang F, Ge F, Li Z (2016) Role of methotrexate chronotherapy in collagen-induced rheumatoid arthritis in rats. Z Rheumatol. \n                    https:\/\/doi.org\/10.1007\/s00393-016-0236-6","journal-title":"Z Rheumatol"},{"issue":"4","key":"464_CR75","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1074-7613(00)80640-8","volume":"9","author":"DD Yang","year":"1998","unstructured":"Yang DD, Conze D, Whitmarsh AJ, Barrett T, Davis RJ, Rincon M et al (1998) Differentiation of CD4\u2009+\u2009T cells to Th1 cells requires MAP kinase JNK2. Immunity 9(4):575\u2013585","journal-title":"Immunity"},{"key":"464_CR76","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/ar4544","volume":"16","author":"L Ye","year":"2014","unstructured":"Ye L, Wen Z, Li Y, Chen B, Yu T, Liu L, Zhang J, Ma Y, Xiao S, Ding L, Li L, Huang Z (2014) Interleukin-10 attenuation of collagen-induced arthritis is associated with suppression of interleukin-17 and retinoid-related orphan receptor \u03b3t production in macrophages and repression of classically activated macrophages. Arthritis Res Ther 16:R96","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"464_CR77","first-page":"500","volume":"17","author":"Y Yoshihara","year":"2007","unstructured":"Yoshihara Y, Yamada H (2007) Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis. Clin Calcium 17(4):500\u2013508","journal-title":"Clin Calcium"},{"issue":"12","key":"464_CR78","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.cellsig.2006.04.003","volume":"18","author":"T Yucel-Lindberg","year":"2006","unstructured":"Yucel-Lindberg T, Olsson T, Kawakami T (2006) Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts. Cell Signal 18(12):2131\u20132142","journal-title":"Cell Signal"}],"updated-by":[{"DOI":"10.1007\/s10787-018-0480-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000}}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-018-0464-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-0464-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-0464-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T19:42:09Z","timestamp":1600285329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-018-0464-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["464"],"URL":"https:\/\/doi.org\/10.1007\/s10787-018-0464-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10787-018-0480-2","asserted-by":"object"}]},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]},"assertion":[{"value":"9 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article can be found online.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article can be found online.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article can be found online.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}